The renal hemodynamic basis of diabetic nephropathy

Seminars in Nephrology

Volumn 17, Issue 2, 1997, Pages 93-100

  O'Bryan, G Thomas ^a   Hosteller, Thomas H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ARTICLE; CAPILLARY PRESSURE; DIABETIC NEPHROPATHY; ENDOTHELIUM INJURY; EPITHELIUM CELL; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; MESANGIUM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; SHEAR STRESS; ULTRAFILTRATION;

EID: 0030907228     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (110)

1. Mogensen CE, Andersen MJF: Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22:706-712, 1973
2. Fiaschi E, Grassi B, Andres G: LaFunZione Renale Nel Diabete Neilito. Ressegna Di Fisiopatolo Gia Clinica E Terapeutica 24:372, 1952
3. Stadier G, Schmid R: Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood. Ann Paediatr 193:129, 1959
4. Ditzel J, Schwanz M: Abnormally increased glomerular filtration rate in short-term insulin-treated diabetic subjects. Diabetes 16:264-267, 1967
5. Morgensen CE: Kidney function and glomerular permeability to macromolecules in early juvenile diabetes. Scand J Clin Lab Invest 28:91, 1971
6. Vora J, Dolben J, Dean J, et al: Renal hemodynamics in newly presenting non-insulin dependent diabetes. Kidney Int 41:829-835, 1992
7. Palrisano JJ, Lebovitz HE: Renal function in Black Americans with Type II diabetes. J Diabetic Complications 3:40-44, 1989
8. Myers BD, Nelson RG, Williams GW, et al: Glomerular function in Pima Indians with non-insulin-dependent diabetes mellitus of recent origin. J Clin Invest 88:524-530, 1991
9. Schmilz A, Christensen T, Taagehoe J, Jensen F: Glomerular filtration rate and kidney volume in normal albuminuric non-insulin-dependent diabetics - Lack of glomerular hyperfiltration and renal hypertrophy in uncomplicated WIDDM. Scand J Clin Lab Invest 49:103-108, 1989
10. Schmilz A, Hansen H, Christensen T: Kidney function in newly diagnosed Type 2 (non-insulin dependent) diabetic patients, before and during treatment. Diabetologia 32:434-439, 1989
11. Nowack MD, Raum E, Blum W, et al: Renal hemodynamics in recent-onset type II diabetes. Am J Kidney Dis 20:342-347, 1992
12. Martin P, Hampton KK, Wallon C, et al: Microproteinuria in Type 2 diabetes from diagnosis. Diabetic Med 7:315-318, 1990
13. Brenner BM, Humes HD: Mechanisms of glomerular Ultrafiltration. N Engl J Med 297:148, 1977
14. Vazquez JJ, Garcia AM: Relation of kidney size to kidney function in early juvenile diabetes. Diabetologia 21:363, 1981
15. Sandahl-Christiansen J, Gammelgaard J, Frandsen M, et al: Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 20:451, 1981
16. Kroustrup JP, Gundersen HJG, Osterby R: Glomerular size and structure in diabetes mellitus. Diabetologia 13:207, 1977
17. Osterby R, Gundersen HJG: Fast accumulation of basement membrane material and the rate of morphological changes in acute experimental diabetic glomerular hypertrophy. Diabetologia 18:493, 1980
18. Hosteller TH, Daniels BS: Nalural history of renal structural abnormalities in diabetes mellitus, in Brenner BM, Stein JH (eds): The Kidney in Diabeles Mellilus. Conlemporary Issues in Nephrology, Vol 20. New York, NY, Churchill Livingstone, 1989, pp 51-56
19. Hirose K, TsuChida H, Osterby R, et al: A strong correlation between glomerular filtration rate and filtration surface in diabetic kidney hyperfiltration. Lab Invest 43:434, 1980
20. Hosteller TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimenlal diabeles. Kidney Int 19:410, 1981
21. Michaels LD, Davidman M, Keane WF: Determinanls of glomerular fillration and plasma flow in experimental diabetic rats. J Lab Clin Med 98:869, 1981
22. Koch-Jensen, Chrisliansen JS, Sleven K, et al: Renal function in diabetic rats. Acta Endocrinol 97:25, 1981 (suppl 42)
23. Gartner K: Glomerular hyperfiltralion during the onset of diabetes mellitus in two strains of diabetic mice. Diabetologia 15:57, 1978
24. Hosteller TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initialion and progression of diabetic and other glomerulopalhies. Am J Med 72:375,1982
25. Zalz R, Brenner BM: Pathogenesis of diabetic microangiopalhy. Am J Med 80:443, 1986
26. Hosteller TH, Olson J, Rennke HG, et al: Hyperfiltration in remnant nephrons: A potenlially adverse response to renal ablalion. Am J Physiol 241:F8J, 1981
27. Steffes MW, Brown DM, Mauer SM: Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27:35, 1978
28. Zatz R, Dunn BR, Meyer TW, et al: Prevention of diabetic glomerulopathy by pharmacological amelioralion of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
29. Zata R, Meyer TW, Rennke HG, et al: Predominance of hemodynamic rather man melabolic factor in the pathogenesis of diabetic glomerulopathy. Proc Natl Aldo Sci USA 82:5963-5967, 1985
30. Anderson S, Rennke HG, Garcia DL, et al: Short and long term effect of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1986
31. Anderson S, Rennke HG, Brenner BM: Nifedipine vs. fosinopril in uninephrectomized diabelic rals. Kidney Int 41:891-897, 1992
32. Cooper ME, Allen TJ, MacMillan P, et al: Genetic hypertension accelerales nephropathy in the streplozolocin diabelic ral. Am J Hypertens 1:5-10, 1988
33. Cooper ME, Alien TJ, O'Brien RL, et al: Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydrolazine and metoprolol therapy. Diabetes 39:1575-1579, 1990
34. Cooper ME, Rumble JR, Alien TJ, et al: Antihypertensive therapy and experimental diabelic nephropathy. Kidney Int 41:898-903, 1992
35. Talkjon B, Debrevi L, Whitly M, et al: Progression of renal disease: Effects of different classes of antihypertensive therapy. J Hypertens 4:5269-5291, 1986 (suppl 5)
36. Brown SA, Walton C, Crawford P, et al: Renal response to angiotensin converting enzyme inhibition (ACE1) or calcium channel blockade (Ca CHB) in diabetic disease. J Am Soc Nephrol 1:309, 1996 (abstr)
37. Fabris B, Jackson B, Johnston CI: Salt blocks the renal benefits of ramipril in diabetic hypertensive rats. Hypertension 17:495-503, 1991
38. Ruddert S, Persson D, Dalquist G: Increased glomerular rate as a predictor of diabetic nephropathy - An 8-year progressive study. Kidney Int 41:822-828, 1992
39. Masuda HK, Kawamura K, Rottda T, et al: Increase in endothelial cell density before enlargement in flow-loaded canine carotid artery. Arteriosclerosis 9:812-823, 1989
40. Langille L, O'Donnell F: Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium dependent. Science 231:405-407, 1986
41. Labarbora M: Principles of design of fluid transplant systems in zoology. Science 249:992-1000, 1990
42. Ballerman BJ, Ott MJ: Adhesion and differentiation of endothelial cells by exposure to chronic shear stress: A vascular graft model. Blood Purification 13:125-134, 1995
43. Ziegelstein RC, Cheng L, Capogrossi MC: Flow-dependent cytosolic acidification of vascular endothelin cells. Science 258:656-659, 1992
44. Franke R, Grape H, Schnittler D, et al: Induction of human vascular endothelial stress fibers by fluid shear stress. Nature 307:648-649, 1984
45. Cooke JP, Standler JS, Andon N, et al: Flow stimulates endothelin cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 28:H804-H812, 1990
46. Diamond SN, Eskin S, Mclntyre L: Fluid flow stimulates tissue plasminogen activated secretion by cultured human endothelial cells. Science 243:1483-148J, 1989
47. Malek A, Izumos: Physiological fluid shear stress causes down regulation of endothelin-1 on RNA in bovine aortic endothelium. Am J Physiol 32:C389-C396, 1992
48. Sharefkin JB, Diamond JL, Eskin G, et al: Fluid flow decreases pre-pro-endothelia in RNA levels and suppresses endothelia-1 peptide release in cultured human endothelial cells. J Vase Surg 14:1-9, 1991
49. Malek AM, Gibbons GH, Dzav VJ, et al: Fluid shear stress differentially modulated expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest 92:2013-2021, 1993
50. Ballerman BJ, Marsden PA: Endothelium derived vasoactive mediators and renal glomerular function. Clin Invest Med 14:508-517, 1991
51. Ausiello DA, Kreisberg JI, Roy C, et al: Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J Clin Invest 65:754, 1980
52. Webb C, Bohr DF: Recent advances in the pathogenesis of hypertension: Consideration of structural, functional, and metabolic vascular abnormalities resulting in elevated arterial resistance. Am Heart 102:251, 1988
53. Leung DYM, Glagov S, Mathews MB: Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 191:475, 1976
54. Harris RC, Haralson MA, Badr KF: Continuous stretch-relaxation in culture alters rat mesangial cell morphology, growth characteristics and metabolic activity. Lab Invest 66:548-554, 1992
55. Riser BL, Cortes D, Zhoa X, et al: Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat. J Clin Invest 90:1932-1943, 1992
56. Yasuda T, Kondo S, Homma T, et al: Mechanisms for accumulation of extracellular matrix in rat mesangial cells in response to stretch/relaxation. J Am Soc Nephrol 5:824, 1994 (abstr)
57. Yasuda T, Becker B, Kondo S, et al: Mechanical stretch/relaxation increases type I angiotensin II receptor expression and angiotensinogen mRNA in cultured rat mesangial cells. J Am Soc Nephrol 5:557, 1994 (abstr)
58. Mauer SM, Steffes MW, Chern M, et al: Mesangial uptake and processing of macromolecules in rats with diabetes mellitus. Lab Invest 41:401, 1079
59. Mauer SM, Steffes MW, Brown DM: The kidney in diabetes. Am J Med 70:603, 1981
60. Velosa JA, Classer RJ, Nevin TE, et al: Experimental model of focal sclerosis. II. Correlation with immunopathologic changes, macromolecular kinetics and polyanion loss. Lab Invest 36:527, 1977
61. Grond J, Schilthuis MS, Koudstaal J, et al: Mesangial function and glomerular sclerosis in rats after unilateral nephrectomy. Kidney Int 22:338, 1982
62. Steffes MW, Brown DM, Mauer SM: Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27:35, 1978
63. Bunn HF, Gabbay KH, Gallop M: The glycosylation of hemoglobin: Relevance to diabetes mellitus. Science 200:21, 1978
64. Miller JA, Gravallese E, Bunn HF: Nonenzymatic glycosylation of erythrocyte membrane proteins. J Clin Invest 65:896, 1980
65. Brownlee M, Cerami A: The biochemistry of the complications of diabetes mellitus. Annu Rev Biochem 50:385, 1981
66. Schober E, Pollak A, Coradello H, et al: Glycosylation of glomerular basement membrane in type I (insulin-dependent) diabetic children. Diabetologia 23:485, 1982
67. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315, 1988
68. Westberg NG, Micheal AF: Immunohistopathology of diabetic glomerulosclerosis. Diabetes 21:163, 1972
69. Miller K, Micheal AF: Immunopathology of renal extracellular membranes in diabetes mellitus: Specificity of tubular basement-membrane immunofluorescence. Diabetes 25:701, 1976
70. Stevens VJ, Rouzer CA, Monnier VM, et al: Diabetic cataract formation: Potential role of glycosylation of lens cystallins. Proc Natl Acad Sci 75:2918, 1978
71. Brownlee M, Vlassara H, Cerami A: Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin. Diabetes 32:680, 1983
72. Daniels BS, Hauser ED: Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model. Diabetes 4:1415-1421, 1992
73. Mogensen CE: Glomerular filtration rate and renal plasma flow in normal and diabetic man during elevation of blood sugar levels. Scand J Clin Lab Invest 28:177, 1971
74. Brochtner-Mortensen J: The glomerular filtration rate during moderate hyperglycemia in man. Acta Med Scand 194:31, 1973
75. Mogensen CE, Steffes MW, Decken T, et al: Functional and morphological renal manifestations in diabetes mellitus. Diabetologia 21:89, 1981
76. Sabbatini M, Sansone G, Uccello F, et al: Early glycosylation products induce glomerular hyperfiltration in normal rats. Kidney Int 42:875-881, 1992
77. Blantz RC, Peterson OW, Gushwa L, et al: Effect of modest hyperglycemia on tubuloglomerular feedback activity. Kidney Int 22:5206, 1982 (suppl 12)
78. Woods LL, Mizelle HL, Hall JO: Control of renal hemodynamics in hyperglycemia. Am J Physiol 252:F65, 1987
79. Seney FD, Salmond R: Tubuloglomerular feedback in diabetic rats. Kidney Int 33:412, 1988
80. Kasiske BL, O'Donnell MP, Keane WF: Glucose-induced increases in renal hemodynamic function: Possible modulation by renal prostaglandins. Diabetes 34:360-364, 1985
81. Juncos LA, Ho S, Carretero O: Effect of insulin of contractility of isolated afferent arterioles (Af-Art). J Am Soc Nephrol 2:251, 1991
82. Kurokawa K, Silverblatt FJ, Klein KL, et al: Binding of 1251-insulin to the isolated glomeruli of the rat kidney. J Clin Invest 64:1357-1364, 1979
83. Schlondorff D: The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1:272-281, 1987
84. Sandahl-Christiansen J, Frandsen M, Parving H-H: The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 20:199, 1981
85. Stackhouse S, Miller PL, Park SK, et al: Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats. Diabetes 39:989-995, 1990
86. Vora JP, Dolben J, Williams JD, et al: Impact of initial treatment on renal function in newly-diagnosed type 2 (noninsulin-dependent) diabetes mellitus. Diabetologia 36:734-740, 1993
87. Unger RH: Diabetes and the alpha cell. Diabetes 25:136-151, 1976
88. LundBaek K: Growth hormones role in diabetic microangiopathy. Diabetes 25:845-849, 1976 (Suppl 2)
89. Parving H-H, Christiansen JS, Noer I, et al: The effect of glucagon infusion on kidney function in short-term insulindependent juvenile diabetes. Diabetologia 19:350, 1980
90. Sandahl-Christiansen J, Gammelgaard J, Orskov H, et al: Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 11:487, 1981
91. Wiseman MJ, Redmond S, House F, et al: The glomerular hyperfiltration of diabetes is not associated with elevated plasma levels of glucagon and growth hormone. Diabetologia 28:718, 1985
92. Serri O, Beauregard H, Brazeau P, et al: Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 265:888, 1991
93. Hirschberg R, Brunori G, Kopple JD, et al: Effects of insulin-like growth factor I on renal function in normal men. Kidney Int 43:387, 1993
94. Hirschberg R, Kopple JD: The growth hormone-insulin-like growth factor I axis and renal glomerular filtration. J Am Soc Nephrol 2:1417, 1992
95. Bank N, Mower P, Aynedjian HS, et al: Sorbinil prevents glomerular hyperperfusion in diabetic rats. Am J Physiol 256:F1000-F1006, 1989
96. Daniels BS, Hosteller TH: Aldose reductase inhibition and glomerular abnormalities in diabetic rats. Diabetes 38:981-986, 1989
97. Christlieb AR: Renin, angiotensin and norepinephrine in alloxan diabetes. Diabetes 23:962, 1974
98. Correa-Rotter R, Hosteller TH, Rosenberg ME: Renin and angiotensinogen gene expression in experimental diabeles. Kidney Inl 41:796-804, 1992
99. Andersen S, Jung FF, Ingelfinger JR: Renal reninangiolensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486, 1993
100. Ballerman BJ, Skorecki KL, Brenner BM: Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in me rat. Am J Physiol 247:F110, 1984
101. Koch-Jensen P, Steven K, Sandahl-Chrisliansen J, el al: The effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29:490, 1986
102. Schambelan M, Blake S, Nirez M-P, et al: Prostaglandin production is increased in glomeruli isolated from rats with streplozotocin-induced diabetes mellitus. Clin Res 3I:440A, 1983
103. Umeda F, Kuroki T, Hawata H: Prostaglandins and diabelic nephropalhy. J Diabeles Complications 9:334-336, 1995
104. Ortola FV, Ballerman BJ, Anderson S, et al: Elevated plasma alrial natriuretic peptide levels in diabelic rais. J Clin Invesl 80:670-674, 1987
105. Zhang PL, Mackenzie HS, Troy JL, el al: Effecls of an alrial nalriurelic peplide receplor anlagonisl on glomerular hyperfillralion in diabetic rais. J Am Soc Nephrol 4:1564-1570, 1994
106. Deng A, Baylis C: Locally produced EDRF conlrols preglomerular resislance and ultrafiltralion coefficient Am J Physiol 264:F212-F215, 1993
107. Korners R, Allen TJ, Cooper ME: Role of endothelium-derived nitric oxide in the palhogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43:1190-1197, 1994
108. Mattar AL, Padilha RM, de Nucci G, et al: Nitric oxide inhibition reverses glomerular hyperfiltration in experimental diabetes, Eliahou HE, laina A, Bar-Khaym Y (eds): in Proceedings of Intemalional Congress of Nephrology, 12th ed. Jerusalem, Blackwell Scienlific, 1993, p 421
109. Tolins JP, Schultz PJ, Raij L, et al: Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: Role of NO. Am J Physiol 265:F886-F895, 1993
110. Mayfield RK, Margolius HS, Levine JH, el al: Urinary kallikrein excrelion in insulin-dependenl diabeles mellitus and its relationship to glycemie control. J Clin Endocrinol Metab 59:278-286, 1984